{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:57:33Z","timestamp":1785459453474,"version":"3.56.0"},"reference-count":128,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100002894","name":"American Academy of Allergy Asthma and Immunology Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002894","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.anai.2026.06.022","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T23:35:30Z","timestamp":1782862530000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Overlapping mechanisms and novel biomarkers define asthma and chronic obstructive pulmonary disease (COPD) as a spectrum of airway diseases"],"prefix":"10.1016","author":[{"given":"Stephen A.","family":"Schworer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2412-5943","authenticated-orcid":false,"given":"Wanda K.","family":"O\u2019Neal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.anai.2026.06.022_bib0001","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jaci.2024.06.004","article-title":"Asthma-COPD coexistence","volume":"154","author":"Barnes","year":"2024","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2026.06.022_bib0002","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jaip.2025.10.033","article-title":"Revisiting type 2 inflammation and airway hyper-responsiveness in COPD","volume":"14","author":"Suter","year":"2026","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.anai.2026.06.022_bib0003","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S2213-2600(22)00185-0","article-title":"Predictors and associations of the persistent airflow limitation phenotype in asthma: a post-hoc analysis of the ATLANTIS study","volume":"11","author":"Kole","year":"2023","journal-title":"Lancet Respir Med"},{"issue":"3","key":"10.1016\/j.anai.2026.06.022_bib0004","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00561-2019","article-title":"Bronchodilator reversibility in asthma and COPD: findings from three large population studies","volume":"54","author":"Janson","year":"2019","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.anai.2026.06.022_bib0005","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1080\/15412555.2021.1980870","article-title":"Current knowledge of asthma-COPD Overlap (ACO) genetic risk factors, characteristics, and prognosis","volume":"18","author":"Odimba","year":"2021","journal-title":"COPD"},{"issue":"1","key":"10.1016\/j.anai.2026.06.022_bib0006","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1038\/s41598-025-32238-w","article-title":"Exploring health consequences of asthma-COPD overlap syndrome in a national study","volume":"16","author":"Wu","year":"2026","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.anai.2026.06.022_bib0007","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev-physiol-042924-084007","article-title":"The developmental origins of asthma and COPD","volume":"88","author":"Polverino","year":"2026","journal-title":"Annu Rev Physiol"},{"issue":"10122","key":"10.1016\/j.anai.2026.06.022_bib0008","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S0140-6736(17)33311-1","article-title":"Asthma","volume":"391","author":"Papi","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.anai.2026.06.022_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.anai.2026.05.034","article-title":"Monoclonal antibodies targeting inflammatory pathways in chronic obstructive pulmonary disease: Evidence and opportunities","author":"Ross","year":"2026","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2026.06.022_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.anai.2026.06.035","article-title":"Biomarkers for COPD with Type 2 Inflammation","author":"Pathak","year":"2026","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.anai.2026.06.022_bib0011","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jaci.2014.06.035","article-title":"Biological clustering supports both \u201cDutch\u201d and \u201cBritish\u201d hypotheses of asthma and chronic obstructive pulmonary disease","volume":"135","author":"Ghebre","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.anai.2026.06.022_bib0012","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1016\/j.jaip.2023.05.013","article-title":"Cluster analyses from the real-world NOVELTY study: six clusters across the asthma-COPD spectrum","volume":"11","author":"Hughes","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.anai.2026.06.022_bib0013","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/ng.3752","article-title":"Genetic loci associated with chronic obstructive pulmonary disease overlap with loci for lung function and pulmonary fibrosis","volume":"49","author":"Hobbs","year":"2017","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.anai.2026.06.022_bib0014","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/all.15666","article-title":"Decoding the genetic and epigenetic basis of asthma","volume":"78","author":"Stikker","year":"2023","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.anai.2026.06.022_bib0015","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.jaci.2021.04.035","article-title":"Inducible expression quantitative trait locus analysis of the MUC5AC gene in asthma in urban populations of children","volume":"148","author":"Altman","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"10342","key":"10.1016\/j.anai.2026.06.022_bib0016","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1016\/S0140-6736(22)00470-6","article-title":"Chronic obstructive pulmonary disease","volume":"399","author":"Christenson","year":"2022","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.anai.2026.06.022_bib0017","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.chest.2021.12.674","article-title":"Genetic associations and architecture of asthma-COPD overlap","volume":"161","author":"John","year":"2022","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.anai.2026.06.022_bib0018","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.jaci.2023.08.002","article-title":"Polygenic risk scores identify heterogeneity in asthma and chronic obstructive pulmonary disease","volume":"152","author":"Moll","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2026.06.022_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105609","article-title":"Identifying chronic obstructive pulmonary disease subtypes using multi-trait genetics","volume":"113","author":"Ziyatdinov","year":"2025","journal-title":"EBioMedicine"},{"issue":"159","key":"10.1016\/j.anai.2026.06.022_bib0020","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0185-2019","article-title":"Asthma-COPD overlap: current understanding and the utility of experimental models","volume":"30","author":"Tu","year":"2021","journal-title":"Eur Respir Rev"},{"issue":"4","key":"10.1016\/j.anai.2026.06.022_bib0021","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.jaci.2022.04.032","article-title":"Airway and parenchymal transcriptomics in a novel model of asthma and COPD overlap","volume":"150","author":"Tu","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2026.06.022_bib0022","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02358-2025","article-title":"The pathobiology and treatment of mucus plugs in asthma and COPD: state of the art","volume":"67","author":"Fahy","year":"2026","journal-title":"Eur Respir J"},{"issue":"8","key":"10.1016\/j.anai.2026.06.022_bib0023","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1164\/rccm.202006-2248OC","article-title":"Mucus plugs and emphysema in the pathophysiology of airflow obstruction and hypoxemia in smokers","volume":"203","author":"Dunican","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.anai.2026.06.022_bib0024","doi-asserted-by":"crossref","first-page":"196","DOI":"10.4168\/aair.2022.14.2.196","article-title":"Mucus plugs and small airway dysfunction in asthma, COPD, and asthma-COPD overlap","volume":"14","author":"Tamura","year":"2022","journal-title":"Allergy Asthma Immunol Res"},{"issue":"6","key":"10.1016\/j.anai.2026.06.022_bib0025","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.resinv.2025.10.007","article-title":"Differential associations between type 2 inflammation and airway mucus plugs in asthma, asthma-COPD overlap, and COPD","volume":"63","author":"Oga","year":"2025","journal-title":"Respir Investig"},{"issue":"3","key":"10.1016\/j.anai.2026.06.022_bib0026","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1172\/JCI95693","article-title":"Mucus plugs in patients with asthma linked to eosinophilia and airflow obstruction","volume":"128","author":"Dunican","year":"2018","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.anai.2026.06.022_bib0027","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1152\/physrev.00023.2019","article-title":"Are we meeting the promise of endotypes and precision medicine in asthma?","volume":"100","author":"Ray","year":"2020","journal-title":"Physiol Rev"},{"issue":"6","key":"10.1016\/j.anai.2026.06.022_bib0028","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.cell.2021.02.016","article-title":"The basic immunology of asthma","volume":"184","author":"Hammad","year":"2021","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.anai.2026.06.022_bib0029","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJMra2032506","article-title":"Biologic therapies for severe asthma","volume":"386","author":"Brusselle","year":"2022","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.anai.2026.06.022_bib0030","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1403290","article-title":"Mepolizumab treatment in patients with severe eosinophilic asthma","volume":"371","author":"Ortega","year":"2014","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1016\/j.anai.2026.06.022_bib0031","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1056\/NEJMoa1804092","article-title":"Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma","volume":"378","author":"Castro","year":"2018","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.anai.2026.06.022_bib0032","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S2213-2600(24)00299-6","article-title":"Treating eosinophilic exacerbations of asthma and COPD with Benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trial","volume":"13","author":"Ramakrishnan","year":"2025","journal-title":"Lancet Respir Med"},{"issue":"9","key":"10.1016\/j.anai.2026.06.022_bib0033","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S2213-2600(17)30217-5","article-title":"Eosinophils in COPD: just another biomarker?","volume":"5","author":"Bafadhel","year":"2017","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.anai.2026.06.022_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105453","article-title":"Distinct physiological, transcriptomic, and imaging characteristics of asthma-COPD overlap compared to asthma and COPD in smokers","volume":"110","author":"Fangal","year":"2024","journal-title":"EBioMedicine"},{"issue":"2","key":"10.1016\/j.anai.2026.06.022_bib0035","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/all.14016","article-title":"Blood eosinophil count and airway epithelial transcriptome relationships in COPD versus asthma","volume":"75","author":"George","year":"2020","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.anai.2026.06.022_bib0036","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.jaci.2013.10.011","article-title":"Sputum neutrophil counts are associated with more severe asthma phenotypes using cluster analysis","volume":"133","author":"Moore","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2026.06.022_bib0037","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1164\/rccm.201807-1291OC","article-title":"A transcriptomic method to determine airway immune dysfunction in T2-high and T2-low asthma","volume":"199","author":"Peters","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.anai.2026.06.022_bib0038","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1111\/crj.12653","article-title":"Investigation of bronchiectasis in severe uncontrolled asthma","volume":"12","author":"Dimakou","year":"2018","journal-title":"Clin Respir J"},{"issue":"6","key":"10.1016\/j.anai.2026.06.022_bib0039","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.jaci.2024.01.027","article-title":"Bronchiectasis and asthma: data from the European Bronchiectasis Registry (EMBARC)","volume":"153","author":"Polverino","year":"2024","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2026.06.022_bib0040","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-02332-w","article-title":"Risk factors for the development of bronchiectasis in patients with asthma","volume":"11","author":"Ma","year":"2021","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.anai.2026.06.022_bib0041","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.resinv.2021.11.004","article-title":"Bronchiectasis in severe asthma and asthmatic components in bronchiectasis","volume":"60","author":"Matsumoto","year":"2022","journal-title":"Respir Investig"},{"issue":"3","key":"10.1016\/j.anai.2026.06.022_bib0042","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00328-2018","article-title":"The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions","volume":"52","author":"Polverino","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.anai.2026.06.022_bib0043","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.2147\/COPD.S132961","article-title":"Bronchiectasis in COPD patients: more than a comorbidity?","volume":"12","author":"Martinez-Garcia","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"8","key":"10.1016\/j.anai.2026.06.022_bib0044","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1164\/rccm.201208-1518OC","article-title":"Prognostic value of bronchiectasis in patients with moderate-to-severe chronic obstructive pulmonary disease","volume":"187","author":"Mart\u00ednez-Garc\u00eda","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.anai.2026.06.022_bib0045","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.anai.2018.02.016","article-title":"Bronchiectasis in severe asthma: clinical features and outcomes","volume":"120","author":"Coman","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"11","key":"10.1016\/j.anai.2026.06.022_bib0046","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1136\/thorax-2022-219158","article-title":"Pulmonary emphysema subtypes defined by unsupervised machine learning on CT scans","volume":"78","author":"Angelini","year":"2023","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.anai.2026.06.022_bib0047","doi-asserted-by":"crossref","first-page":"00177","DOI":"10.1183\/23120541.00177-2024","article-title":"What every clinician should know about inflammation in COPD","volume":"10","author":"Wechsler","year":"2024","journal-title":"ERJ Open Res"},{"issue":"4","key":"10.1016\/j.anai.2026.06.022_bib0048","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1001\/jama.2024.22684","article-title":"Transcriptomic profiles in nasal epithelium and asthma endotypes in youth","volume":"333","author":"Yue","year":"2025","journal-title":"JAMA."},{"issue":"1","key":"10.1016\/j.anai.2026.06.022_bib0049","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1172\/JCI121087","article-title":"An airway epithelial IL-17A response signature identifies a steroid-unresponsive COPD patient subgroup","volume":"129","author":"Christenson","year":"2019","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.anai.2026.06.022_bib0050","doi-asserted-by":"crossref","DOI":"10.1111\/imr.70011","article-title":"T1-T2 interplay in the complex immune landscape of severe asthma","volume":"330","author":"Gauthier","year":"2025","journal-title":"Immunol Rev"},{"issue":"2","key":"10.1016\/j.anai.2026.06.022_bib0051","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.chest.2021.09.036","article-title":"Asthma-COPD overlap: what are the important questions?","volume":"161","author":"Leung","year":"2022","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.anai.2026.06.022_bib0052","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.jaci.2021.01.037","article-title":"PrecISE: precision medicine in severe asthma: an adaptive platform trial with biomarker ascertainment","volume":"147","author":"Israel","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2026.06.022_bib0053","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105800","article-title":"Proteomic biomarkers of emphysema-predominant and non-emphysema-predominant chronic obstructive pulmonary disease","volume":"117","author":"Zhang","year":"2025","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.anai.2026.06.022_bib0054","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/s12967-024-05100-2","article-title":"An integrated metabo-lipidomics profile of induced sputum for the identification of novel biomarkers in the differential diagnosis of asthma and COPD","volume":"22","author":"Correnti","year":"2024","journal-title":"J Transl Med"},{"issue":"11","key":"10.1016\/j.anai.2026.06.022_bib0055","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1038\/nm.2971","article-title":"Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression","volume":"18","author":"Galb\u00e1n","year":"2012","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.anai.2026.06.022_bib0056","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1164\/rccm.202409-1820OC","article-title":"Mechanically affected lung and progression of emphysema","volume":"211","author":"Bhatt","year":"2025","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.anai.2026.06.022_bib0057","doi-asserted-by":"crossref","first-page":"7818","DOI":"10.1038\/s41598-019-44345-6","article-title":"Physiological and morphological differences of airways between COPD and asthma-COPD overlap","volume":"9","author":"Karayama","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.anai.2026.06.022_bib0058","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.2147\/COPD.S469956","article-title":"Differences in the quantitative HRCT characteristics of patients with asthma, COPD and asthma-COPD overlap and their relationships with pulmonary function","volume":"19","author":"Lu","year":"2024","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.anai.2026.06.022_bib0060","unstructured":"GOLD report. Global Initiative for Chronic Obstructive Lung Disease. Accessed May 30, 2026. Available at: https:\/\/goldcopd.org\/2025-gold-report\/"},{"issue":"12","key":"10.1016\/j.anai.2026.06.022_bib0061","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1002\/ppul.27183","article-title":"Machine learning-enhanced HRCT analysis for diagnosis and severity assessment in pediatric asthma","volume":"59","author":"De Filippo","year":"2024","journal-title":"Pediatr Pulmonol."},{"issue":"1","key":"10.1016\/j.anai.2026.06.022_bib0062","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1148\/radiol.2021204616","article-title":"Mucus plugs in asthma at CT associated with regional ventilation defects at 3He MRI","volume":"303","author":"Mummy","year":"2022","journal-title":"Radiology"},{"issue":"10","key":"10.1016\/j.anai.2026.06.022_bib0063","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1164\/rccm.202305-0802OC","article-title":"A novel air trapping segment score identifies opposing effects of obesity and eosinophilia on air trapping in asthma","volume":"209","author":"Leung","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"issue":"suppl 3","key":"10.1016\/j.anai.2026.06.022_bib0064","doi-asserted-by":"crossref","first-page":"S184","DOI":"10.1513\/AnnalsATS.201807-485AW","article-title":"Autopsy and imaging studies of mucus in asthma. Lessons learned about disease mechanisms and the role of mucus in airflow obstruction","volume":"15","author":"Dunican","year":"2018","journal-title":"Ann Am Thorac Soc"},{"issue":"3","key":"10.1016\/j.anai.2026.06.022_bib0065","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jaip.2025.11.028","article-title":"Mucus plugs and eosinophilic inflammation: expanding the paradigm to COPD","volume":"14","author":"Ueki","year":"2026","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"9","key":"10.1016\/j.anai.2026.06.022_bib0066","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1164\/rccm.202110-2265OC","article-title":"Mucus plugs persist in asthma, and changes in mucus plugs associate with changes in airflow over time","volume":"205","author":"Tang","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.anai.2026.06.022_bib0067","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.chest.2025.08.042","article-title":"Biologic management in severe asthma for adults: an American College of Chest Physicians Clinical Practice guideline","volume":"169","author":"Oberle","year":"2026","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.anai.2026.06.022_bib0068","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1146\/annurev-med-070323-103158","article-title":"Biologic medications for severe asthma: implications for understanding pathogenic heterogeneity and endotypes","volume":"76","author":"Ramonell","year":"2025","journal-title":"Annu Rev Med"},{"issue":"10516","key":"10.1016\/j.anai.2026.06.022_bib0069","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1016\/S0140-6736(25)01625-3","article-title":"Anti-cytokine biologics for asthma in adults","volume":"406","author":"Israel","year":"2025","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.anai.2026.06.022_bib0070","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1056\/NEJMoa1704064","article-title":"Tezepelumab in adults with uncontrolled asthma","volume":"377","author":"Corren","year":"2017","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.anai.2026.06.022_bib0071","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S2213-2600(15)00042-9","article-title":"Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials","volume":"3","author":"Castro","year":"2015","journal-title":"Lancet Respir Med"},{"issue":"25","key":"10.1016\/j.anai.2026.06.022_bib0072","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1056\/NEJMoa1703501","article-title":"Oral glucocorticoid-sparing effect of Benralizumab in severe asthma","volume":"376","author":"Nair","year":"2017","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.anai.2026.06.022_bib0073","doi-asserted-by":"crossref","first-page":"9825","DOI":"10.1038\/s41598-023-36642-y","article-title":"Tozorakimab (MEDI3506): an anti-IL-33 antibody that inhibits IL-33 signalling via ST2 and RAGE\/EGFR to reduce inflammation and epithelial dysfunction","volume":"13","author":"England","year":"2023","journal-title":"Sci Rep"},{"issue":"822","key":"10.1016\/j.anai.2026.06.022_bib0074","doi-asserted-by":"crossref","first-page":"eadu3759","DOI":"10.1126\/scitranslmed.adu3759","article-title":"The IL-33 and IL-4R\u03b1 blocking antibodies itepekimab and dupilumab modulate both distinct and common inflammatory mediators in asthma","volume":"17","author":"Asrat","year":"2025","journal-title":"Sci Transl Med"},{"issue":"4","key":"10.1016\/j.anai.2026.06.022_bib0075","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.jaci.2025.01.017","article-title":"Targeting alarmins in asthma: from the bench to the clinic","volume":"155","author":"Akenroye","year":"2025","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2026.06.022_bib0076","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jaci.2021.03.044","article-title":"Astegolimab (anti-ST2) efficacy and safety in adults with severe asthma: a randomized clinical trial","volume":"148","author":"Kelsen","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"10543","key":"10.1016\/j.anai.2026.06.022_bib0077","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/S0140-6736(26)00637-9","article-title":"Safety and efficacy of astegolimab for COPD with frequent exacerbations regardless of baseline blood eosinophil counts (ALIENTO and ARNASA): randomised, double-blind, placebo-controlled, phase 2b and 3 trials","volume":"407","author":"Papi","year":"2026","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.anai.2026.06.022_bib0078","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S2213-2600(25)00044-X","article-title":"Type 2 inflammation biomarkers and their association with response to dupilumab in COPD (BOREAS): an analysis of a randomised, placebo-controlled, phase 3 trial","volume":"13","author":"Christenson","year":"2025","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10.1016\/j.anai.2026.06.022_bib0079","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S2213-2600(24)00324-2","article-title":"Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial","volume":"13","author":"Singh","year":"2025","journal-title":"Lancet Respir Med"},{"issue":"5","key":"10.1016\/j.anai.2026.06.022_bib0080","doi-asserted-by":"crossref","first-page":"00718","DOI":"10.1183\/23120541.00718-2023","article-title":"AERIFY-1\/2: two phase 3, randomised, controlled trials of itepekimab in former smokers with moderate-to-severe COPD","volume":"10","author":"Rabe","year":"2024","journal-title":"ERJ Open Res"},{"issue":"2","key":"10.1016\/j.anai.2026.06.022_bib0081","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3390\/jpm16020108","article-title":"Dupilumab in severe asthma-COPD overlap: real-life experience on a case series","volume":"16","author":"Sposato","year":"2026","journal-title":"J Pers Med"},{"issue":"17","key":"10.1016\/j.anai.2026.06.022_bib0082","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1056\/NEJMoa2413181","article-title":"Mepolizumab to prevent exacerbations of COPD with an eosinophilic phenotype","volume":"392","author":"Sciurba","year":"2025","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.anai.2026.06.022_bib0083","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1183\/13993003.01359-2015","article-title":"Treatable traits: toward precision medicine of chronic airway diseases","volume":"47","author":"Agusti","year":"2016","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.anai.2026.06.022_bib0084","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S2213-2600(19)30055-4","article-title":"Shared and distinct genetic risk factors for childhood-onset and adult-onset asthma: genome-wide and transcriptome-wide studies","volume":"7","author":"Pividori","year":"2019","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.anai.2026.06.022_bib0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2022.107038","article-title":"Integrating digital inhalers into clinical care of patients with asthma and chronic obstructive pulmonary disease","volume":"205","author":"Pleasants","year":"2022","journal-title":"Respir Med"},{"issue":"12","key":"10.1016\/j.anai.2026.06.022_bib0086","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S2352-4642(21)00268-6","article-title":"Pharmacogenetic studies of long-acting beta agonist and inhaled corticosteroid responsiveness in randomised controlled trials of individuals of African descent with asthma","volume":"5","author":"Ortega","year":"2021","journal-title":"Lancet Child Adolesc Health"},{"issue":"4","key":"10.1016\/j.anai.2026.06.022_bib0087","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.jaci.2024.01.014","article-title":"Analytical challenges in omics research on asthma and allergy: a National Institute of Allergy and Infectious Diseases workshop","volume":"153","author":"Bunyavanich","year":"2024","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2026.06.022_bib0088","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jaci.2024.06.010","article-title":"Precision medicine for asthma treatment: unlocking the potential of the epigenome and microbiome","volume":"155","author":"Perez-Garcia","year":"2025","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2026.06.022_bib0089","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4168\/aair.2026.18.1.67","article-title":"Genome-wide association study identifies IL1RL1 and KIAA1217 associated with asthma-chronic obstructive pulmonary disease overlap in the all of Us research program","volume":"18","author":"Li","year":"2026","journal-title":"Allergy Asthma Immunol Res"},{"issue":"1","key":"10.1016\/j.anai.2026.06.022_bib0090","article-title":"Clustering-based COPD subtypes have distinct longitudinal outcomes and multi-omics biomarkers","volume":"9","author":"Gregory","year":"2022","journal-title":"BMJ Open Respir Res"},{"issue":"8","key":"10.1016\/j.anai.2026.06.022_bib0091","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/s41576-024-00695-0","article-title":"Genetics of chronic respiratory disease","volume":"25","author":"Sayers","year":"2024","journal-title":"Nat Rev Genet."},{"issue":"2","key":"10.1016\/j.anai.2026.06.022_bib0092","doi-asserted-by":"crossref","first-page":"170","DOI":"10.4168\/aair.2019.11.2.170","article-title":"Lessons learned from GWAS of asthma","volume":"11","author":"Kim","year":"2019","journal-title":"Allergy Asthma Immunol Res"},{"issue":"1","key":"10.1016\/j.anai.2026.06.022_bib0093","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S2213-2600(18)30389-8","article-title":"Moderate-to-severe asthma in individuals of European ancestry: a genome-wide association study","volume":"7","author":"Shrine","year":"2019","journal-title":"Lancet Respir Med"},{"issue":"11","key":"10.1016\/j.anai.2026.06.022_bib0094","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S2213-2600(25)00256-5","article-title":"Genetic and environmental risk factors for asthma: towards prevention","volume":"13","author":"Koppelman","year":"2025","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10.1016\/j.anai.2026.06.022_bib0095","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/all.14528","article-title":"A mouse model of asthma-chronic obstructive pulmonary disease overlap induced by intratracheal papain","volume":"76","author":"Fukuda","year":"2021","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.anai.2026.06.022_bib0096","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12931-024-02774-6","article-title":"Early-life house dust mite aeroallergen exposure augments cigarette smoke-induced myeloid inflammation and emphysema in mice","volume":"25","author":"Fung","year":"2024","journal-title":"Respir Res"},{"issue":"1","key":"10.1016\/j.anai.2026.06.022_bib0097","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12950-022-00322-x","article-title":"Evaluation of asthma-chronic obstructive pulmonary disease overlap using a mouse model of pulmonary disease","volume":"19","author":"Jo","year":"2022","journal-title":"J Inflamm (Lond)"},{"key":"10.1016\/j.anai.2026.06.022_bib0098","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.149831","article-title":"Airway inflammation in a novel mouse model of asthma-COPD overlap induced by co-exposure to papain and tobacco smoke","volume":"709","author":"Kimura","year":"2024","journal-title":"Biochem Biophys Res Commun"},{"issue":"21","key":"10.1016\/j.anai.2026.06.022_bib0099","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1001\/jama.2023.2065","article-title":"Airway-occluding mucus plugs and mortality in patients with chronic obstructive pulmonary disease","volume":"329","author":"Diaz","year":"2023","journal-title":"JAMA"},{"issue":"178","key":"10.1016\/j.anai.2026.06.022_bib0100","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0110-2025","article-title":"A translational view of airway epithelial dysfunction in COPD","volume":"34","author":"Brightling","year":"2025","journal-title":"Eur Respir Rev"},{"issue":"4","key":"10.1016\/j.anai.2026.06.022_bib0101","doi-asserted-by":"crossref","first-page":"L473","DOI":"10.1152\/ajplung.00137.2022","article-title":"Differential airway remodeling changes were observed in patients with asthma COPD overlap compared to patients with asthma and COPD alone","volume":"323","author":"Dey","year":"2022","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"10.1016\/j.anai.2026.06.022_bib0102","doi-asserted-by":"crossref","first-page":"L64","DOI":"10.1152\/ajplung.00121.2021","article-title":"Pathogenesis, clinical features of asthma COPD overlap, and therapeutic modalities","volume":"322","author":"Dey","year":"2022","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"6","key":"10.1016\/j.anai.2026.06.022_bib0103","doi-asserted-by":"crossref","DOI":"10.1172\/JCI186889","article-title":"Cellular and molecular features of asthma mucus plugs provide clues about their formation and persistence","volume":"135","author":"Liegeois","year":"2025","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.anai.2026.06.022_bib0104","article-title":"Type 2 inflammation in COPD: is it just asthma?","volume":"20","author":"Beech","year":"2024","journal-title":"Breathe (Sheff)"},{"key":"10.1016\/j.anai.2026.06.022_bib0105","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2023.1113100","article-title":"Airway remodeling heterogeneity in asthma and its relationship to disease outcomes","volume":"14","author":"Hsieh","year":"2023","journal-title":"Front Physiol"},{"issue":"5","key":"10.1016\/j.anai.2026.06.022_bib0106","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1164\/rccm.202408-1544OC","article-title":"Clinical and biological features of a thickened basement membrane zone in asthma","volume":"211","author":"Leung","year":"2025","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.anai.2026.06.022_bib0107","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jaci.2017.04.027","article-title":"Pulmonary inflammation in patients with chronic obstructive pulmonary disease with higher blood eosinophil counts","volume":"140","author":"Kolsum","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2026.06.022_bib0108","first-page":"127","article-title":"Reticular basement membrane in asthma and COPD: similar thickness, yet different composition","volume":"4","author":"Liesker","year":"2009","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"4","key":"10.1016\/j.anai.2026.06.022_bib0109","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1164\/rccm.202111-2634OC","article-title":"Heterogeneity of airway smooth muscle remodeling in asthma","volume":"207","author":"James","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.anai.2026.06.022_bib0110","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00218-2023","article-title":"Airway smooth muscle area to predict steroid responsiveness in COPD patients receiving triple therapy (HISTORIC): a randomised, placebo-controlled, double-blind, investigator-initiated trial","volume":"62","author":"Stolz","year":"2023","journal-title":"Eur Respir J"},{"issue":"10379","key":"10.1016\/j.anai.2026.06.022_bib0111","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0140-6736(22)02125-0","article-title":"Asthma","volume":"401","author":"Porsbjerg","year":"2023","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.anai.2026.06.022_bib0112","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1164\/rccm.202303-0455CI","article-title":"Targeting type 2 inflammation and epithelial alarmins in chronic obstructive pulmonary disease: a biologics outlook","volume":"208","author":"Rabe","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.anai.2026.06.022_bib0113","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200903-0392OC","article-title":"T-helper type 2-driven inflammation defines major subphenotypes of asthma","volume":"180","author":"Woodruff","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.anai.2026.06.022_bib0114","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1164\/rccm.201408-1458OC","article-title":"Asthma-COPD overlap. Clinical relevance of genomic signatures of type 2 inflammation in chronic obstructive pulmonary disease","volume":"191","author":"Christenson","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.anai.2026.06.022_bib0115","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.chest.2018.07.002","article-title":"Predictors of asthma\/copd overlap in FDNY firefighters with world trade center dust exposure: a longitudinal study","volume":"154","author":"Singh","year":"2018","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.anai.2026.06.022_bib0116","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.jaip.2019.11.006","article-title":"T2-\u201clow\u201d asthma: overview and management strategies","volume":"8","author":"Fitzpatrick","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"7","key":"10.1016\/j.anai.2026.06.022_bib0117","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S2213-2600(16)30048-0","article-title":"Plasma interleukin-6 concentrations, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohorts","volume":"4","author":"Peters","year":"2016","journal-title":"Lancet Respir Med"},{"issue":"2","key":"10.1016\/j.anai.2026.06.022_bib0118","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1152\/physrev.00025.2015","article-title":"The contribution of small airway obstruction to the pathogenesis of chronic obstructive pulmonary disease","volume":"97","author":"Hogg","year":"2017","journal-title":"Physiol Rev"},{"issue":"1","key":"10.1016\/j.anai.2026.06.022_bib0119","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.chest.2021.03.047","article-title":"Seven pillars of small airways disease in asthma and COPD: supporting opportunities for novel therapies","volume":"160","author":"Usmani","year":"2021","journal-title":"Chest"},{"issue":"25","key":"10.1016\/j.anai.2026.06.022_bib0120","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1056\/NEJM196806202782501","article-title":"Site and nature of airway obstruction in chronic obstructive lung disease","volume":"278","author":"Hogg","year":"1968","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1016\/j.anai.2026.06.022_bib0121","doi-asserted-by":"crossref","first-page":"eaao4747","DOI":"10.1126\/sciimmunol.aao4747","article-title":"Neutrophil cytoplasts induce TH17 differentiation and skew inflammation toward neutrophilia in severe asthma","volume":"3","author":"Krishnamoorthy","year":"2018","journal-title":"Sci Immunol"},{"issue":"5","key":"10.1016\/j.anai.2026.06.022_bib0122","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01846-2019","article-title":"Neutrophilic asthma: welcome back!","volume":"54","author":"Gibson","year":"2019","journal-title":"Eur Respir J"},{"issue":"10351","key":"10.1016\/j.anai.2026.06.022_bib0123","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0140-6736(22)01198-9","article-title":"Mepolizumab for urban children with exacerbation-prone eosinophilic asthma in the USA (MUPPITS-2): a randomised, double-blind, placebo-controlled, parallel-group trial","volume":"400","author":"Jackson","year":"2022","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.anai.2026.06.022_bib0124","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/S2213-2600(21)00004-7","article-title":"The inflammatory profile of exacerbations in patients with severe refractory eosinophilic asthma receiving mepolizumab (the MEX study): a prospective observational study","volume":"9","author":"McDowell","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"4","key":"10.1016\/j.anai.2026.06.022_bib0125","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1164\/rccm.202206-1230OC","article-title":"Low CC16 mRNA expression levels in bronchial epithelial cells are associated with asthma severity","volume":"207","author":"Li","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.anai.2026.06.022_bib0126","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/s41467-025-67436-7","article-title":"The ratio of circulatory levels of sphingolipids to steroids predicts asthma exacerbations","volume":"17","author":"Chen","year":"2026","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.anai.2026.06.022_bib0127","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12931-025-03242-5","article-title":"Exhaled volatile organic compounds as novel biomarkers for early detection of COPD, asthma, and PRISm: a cross-sectional study","volume":"26","author":"Tian","year":"2025","journal-title":"Respir Res"},{"issue":"2","key":"10.1016\/j.anai.2026.06.022_bib0128","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2500051","article-title":"A quantitative lung mucin score to identify chronic bronchitis","volume":"5","author":"Kesimer","year":"2026","journal-title":"NEJM Evid"},{"key":"10.1016\/j.anai.2026.06.022_bib0129","doi-asserted-by":"crossref","DOI":"10.3389\/falgy.2025.1670783","article-title":"Machine learning-derived genetic risk scores identify IL21 as a predictor of response to omalizumab and dupilumab in asthma","volume":"6","author":"Akenroye","year":"2025","journal-title":"Front Allergy"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120626002929?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120626002929?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T23:57:30Z","timestamp":1785455850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120626002929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":128,"alternative-id":["S1081120626002929"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2026.06.022","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overlapping mechanisms and novel biomarkers define asthma and chronic obstructive pulmonary disease (COPD) as a spectrum of airway diseases","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2026.06.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}